Literature DB >> 19457840

Freehand versus guided breast biopsy: comparison of accuracy, needle motion, and biopsy time in a tissue model.

Nathan Bluvol1, Anat Kornecki, Allison Shaikh, David Del Rey Fernandez, Donald H Taves, Aaron Fenster.   

Abstract

OBJECTIVE: Freehand ultrasound-guided breast biopsy may present difficulties in needle visualization within the scanning plane of the ultrasound image. Scanning plane and needle misalignment, an unknown needle insertion site (relative to the ultrasound image), needle trajectory before insertion, and physician experience play roles in the difficulty of these biopsy procedures. The objective of our study was to compare the currently used freehand technique with the use of a needle guidance system that limits needle motion to within the ultrasound scanning plane for breast biopsy.
MATERIALS AND METHODS: We developed a needle guidance system for breast biopsy that is composed of an electronically tracked passive mechanical arm and braking mechanism. The system was attached to an ultrasound transducer, and biopsy needles were inserted through the guidance arm. Both experienced and inexperienced radiologists performed ultrasound-guided biopsy on simulated breast lesions with and without the guidance system. Success rates were scored on the basis of the presence of lesions in the core biopsy samples. The biopsy procedures were analyzed using procedure time and total needle tip travel distance before firing.
RESULTS: The biopsy success rates were greater using the guidance system (p < 0.05) than using the freehand technique. Experienced radiologists and inexperienced radiologists performed biopsy significantly faster using the needle guidance system (p < 0.001). Additionally, needle tip motion was significantly greater when using the freehand technique (p < 0.001) than using the guidance system.
CONCLUSION: Biopsy using the developed needle guidance system is feasible and its use decreases procedure time and decreases needle motion; thus, it has the potential to reduce patient morbidity. Moreover, less operator experience is required for a successful breast biopsy using the needle guidance system than using the freehand technique.

Entities:  

Mesh:

Year:  2009        PMID: 19457840     DOI: 10.2214/AJR.08.1434

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review.

Authors:  Rongrong Guo; Guolan Lu; Binjie Qin; Baowei Fei
Journal:  Ultrasound Med Biol       Date:  2017-10-26       Impact factor: 2.998

2.  Body-mounted robotic instrument guide for image-guided cryotherapy of renal cancer.

Authors:  Nobuhiko Hata; Sang-Eun Song; Olutayo Olubiyi; Yasumichi Arimitsu; Kosuke Fujimoto; Takahisa Kato; Kemal Tuncali; Soichiro Tani; Junichi Tokuda
Journal:  Med Phys       Date:  2016-02       Impact factor: 4.071

3.  Breast biopsy navigation system with an assisted needle holder tool and 2D graphical user interface.

Authors:  Jackrit Suthakorn; Narucha Tanaiutchawoot; Cholatip Wiratkapan; Songpol Ongwattanakul
Journal:  Eur J Radiol Open       Date:  2018-07-18

4.  Benefits of contrast-enhanced ultrasonography for interventional procedures.

Authors:  Constantin Arndt Marschner; Johannes Rübenthaler; Matthias Frank Froelich; Vincent Schwarze; Dirk-André Clevert
Journal:  Ultrasonography       Date:  2020-11-19

5.  The Use of a New Device-Assisted Needle Guidance versus Conventional Approach to Perform Ultrasound Guided Brachial Plexus Blockade: A Randomized Controlled Study.

Authors:  Amaresh Vydyanathan; Priya Agrawal; Naveen Shetty; Singh Nair; Nancy Shilian; Naum Shaparin
Journal:  Local Reg Anesth       Date:  2022-07-25

6.  Simulation-based cutaneous surgical-skill training on a chicken-skin bench model in a medical undergraduate program.

Authors:  Rafael Denadai; Rogério Saad-Hossne; Luís Ricardo Martinhão Souto
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.